市场调查报告书
商品编码
1359584
羧基疗法市场规模-按产品类型(台式、便携式)、按应用(美容医学、妇科、血管学、骨科和风湿病、运动医学)、按最终用途(医院、美容诊所、MedSpa)-2023年全球预测- 2032Carboxy Therapy Market Size-By Product Type (Table Top, Portable), By Application (Aesthetic Medicine, Gynecology, Angiology, Orthopaedics and Rheumatology, Sports Medicine), By End-use (Hospitals, Aesthetic Clinics, MedSpa)-Global Forecast 2023-2032 |
在全球美学和外观增强意识不断增强的推动下,羧基疗法市场规模预计从 2023 年到 2032 年复合年增长率将达到 12.2%。近年来,在社群媒体和视觉文化的持续发展趋势中,人们越来越注重自己的外表,并寻求非侵入性治疗来增强自己的美丽。这增加了对羧基疗法的需求,进一步为皮肤再生和身体轮廓提供多功能解决方案,以满足对微创美容手术不断增长的需求。对美学和自我形象的日益关注预计也将影响行业的成长。
整个羧基治疗市场分为产品类型、应用、最终用途和地区。
根据产品类型,便携式细分市场的行业价值预计将在 2023 年至 2032 年期间获得成长。便携式羧基治疗设备提供便利性和多功能性,使治疗能够在各种临床环境、水疗中心和家庭中进行。此外,这些设备的紧凑性和用户友好性使其在医生和患者中广受欢迎,因为它们易于使用和移动。嫩肤、减少脂肪团和疤痕治疗方面的成本效益优势,为更广泛的受众提供可及性,也将有助于该细分市场的成长。
妇科应用领域的羧基治疗市场预计到 2032 年将产生可观的收入。这种增长可归因于针对各种妇科疾病的非侵入性有效治疗方法的广泛普及。根据 NCBI 2023 年 8 月发布的一项研究,估计全球有超过 4.23 亿 20 岁及以上的人患有尿失禁。此外,阴道鬆弛和性功能障碍的盛行率不断上升,促使女性采用羧基疗法作为改善私密健康的非手术选择,进一步影响了该细分市场的成长。
预计到2032年,亚太地区羧基治疗市场规模将出现强劲增长。这归因于中产阶级人口的不断扩大、可支配收入的增加、对非侵入性美容治疗意识的不断提高以及对年轻和健康外观的日益增长的渴望肌肤。此外,韩国和泰国等医疗旅游目的地已经普及了该手术,吸引了来自世界各地的患者,从而支持了该行业的成长。
Carboxy Therapy Market size is projected to witness 12.2% CAGR from 2023 to 2032, driven by the increasing awareness of aesthetics and appearance enhancement worldwide. In recent years, individuals have grown increasingly conscious of their appearance and are seeking non-invasive treatments to enhance their beauty amidst the ongoing trends of social media and visual culture. This has surged the demand for carboxy therapy, further offering versatile solutions for skin rejuvenation and body contouring to match the rising demand for minimally invasive aesthetic procedures. The growing focus on aesthetics and self-image is also expected to influence the industry growth.
The overall carboxy therapy market is segmented into product type, application, end-use, and region.
Based on product type, the industry value from the portable segment is poised to gain traction from 2023 to 2032. Portable carboxy therapy devices offer convenience and versatility, enabling treatments to be performed in various clinical settings, spas, and at home. Moreover, the compact and user-friendly nature of these devices has surged their popularity among practitioners and patients to offer ease of use and mobility. Advantages of cost-effectiveness in skin rejuvenation, cellulite reduction, and scar therapy to render accessibility to broader audience will also contribute to the segment growth.
Carboxy therapy market from the gynecology application segment is expected to generate considerable revenue by 2032. The growth can be attributed to the significant popularity of non-invasive and effective treatment methods for various gynecological conditions. According to a study published by NCBI in August 2023, it is estimated that over 423 million persons aged 20 years and older globally suffer from urine incontinence. In addition, the rising prevalence of vaginal laxity, and sexual dysfunction is surging the adoption of carboxy therapy among women as non-surgical option for improving intimate health, further influencing the segment growth.
Asia Pacific carboxy therapy market size is expected to witness robust growth through 2032. This is attributed to the expanding middle-class population with increased disposable incomes, the rising awareness of non-invasive aesthetic treatments, and the growing desire for youthful and healthy-looking skin. Moreover, medical tourism destinations, such as South Korea and Thailand have popularized the procedure, attracting patients from around the world, in turn, supporting the industry growth.